Stock UniverseDerived research view · source repositories remain read-only

Crescent Biopharma, Inc. (CBIO)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
22.16
Global Rank
3072
Market Cap
236.36M
Latest Close
18.00
RS Composite
21.12% · G#433

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-0.33%
3M
49.13%
6M
34.23%
1Y
-14.29%
3Y
-90.32%
5Y
-106.42%
10Y
-101.99%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 192.40K · 30-day average: 295.31K · Max drawdown over stored range: -97.79%

Research Snapshot

Relative Strength vs SPX

RS Composite21.12%
20D RS-0.64%
60D RS42.54%
120D RS10.57%
Global RS Rank433 · 87.09% percentile
Watch+Speculative RS Rank255 · 87.84% percentile
Group ScopeWatch+Speculative
Primary RS Rank67 · 85.37% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank370 / 701
Primary Percentile47.36
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for CBIO.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1.15980.0750.0110.844
Revenue Growth (YoY)-88.588%-93.533%-86.667%
Gross Profit
Operating Income-68.764
Free Cash Flow-57.5045-46.5417-34.9013-6.269-72.451
Free Cash Flow Per Share-111.76072339440708-88.59821005710266-55.09936659395873-9.722809358693327-6.957311505313843
EPS (Diluted) GAAP-13.454129
EPS Growth
EPS Non-GAAP
Gross Margin100%100%100%100%
Operating Margin-5470.6855%-63204.4293%-392752.93%-1407.52%
Profit Margin-5468.981%-62251.736%-368994.2%-1419.61%
Free Cash Flow Margin-4958.2781%-62055.572%-349012.97%-668.121%
Shares Outstanding (Diluted)0.51450.52530.63345.31210.4136
Shares Change (YoY)12.537%2.095%20.581%1.792%1515.089%

SEC Quarterly Fundamentals

No processed quarterly rows for CBIO.